Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Oncology Letters
|
October 11, 2021
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Tomoya Kato, Mikihito Nakamori, Shuichi Matsumura, et al.
Neuro-Oncology
|
April 13, 2019
Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background
Boonmin Poh, Hideto Koso, Hiroyuki Momota, et al.
Molecular Therapy Oncolytics
|
May 26, 2022
Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models
Masahiko Hatta, Masaki Kaibori, Hideyuki Matsushima, et al.
Oncology Letters
|
May 10, 2021
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Tomoya Kato, Mikihito Nakamori, Shuichi Matsumura, et al.
Journal of Neurosurgery
|
February 10, 2009
The motor-evoked potential threshold evaluated by tractography and electrical stimulation
Kyousuke Kamada, Tomoki Todo, Takahiro Ota, et al.
Journal of Neurosurgery
|
May 6, 2005
Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation
Kyousuke Kamada, Tomoki Todo, Yoshitaka Masutani, et al.
Molecular Therapy Oncolytics
|
September 23, 2021
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
Toshihiro Uchihashi, Hirokazu Nakahara, Hiroshi Fukuhara, et al.
The Journal of Gene Medicine
|
March 9, 2005
Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models
Kenji Nakano, Tomoki Todo, Gang Zhao, et al.
Cancer Science
|
September 5, 2019
Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis
Erna Raja, Masato Morikawa, Jun Nishida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 19, 2006
Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy
Ta-Chiang Liu, Tingguo Zhang, Hiroshi Fukuhara, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Oncology Letters
|
October 11, 2021
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Tomoya Kato, Mikihito Nakamori, Shuichi Matsumura, et al.
Neuro-Oncology
|
April 13, 2019
Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background
Boonmin Poh, Hideto Koso, Hiroyuki Momota, et al.
Molecular Therapy Oncolytics
|
May 26, 2022
Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models
Masahiko Hatta, Masaki Kaibori, Hideyuki Matsushima, et al.
Oncology Letters
|
May 10, 2021
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Tomoya Kato, Mikihito Nakamori, Shuichi Matsumura, et al.
Journal of Neurosurgery
|
February 10, 2009
The motor-evoked potential threshold evaluated by tractography and electrical stimulation
Kyousuke Kamada, Tomoki Todo, Takahiro Ota, et al.
Journal of Neurosurgery
|
May 6, 2005
Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation
Kyousuke Kamada, Tomoki Todo, Yoshitaka Masutani, et al.
Molecular Therapy Oncolytics
|
September 23, 2021
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
Toshihiro Uchihashi, Hirokazu Nakahara, Hiroshi Fukuhara, et al.
The Journal of Gene Medicine
|
March 9, 2005
Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models
Kenji Nakano, Tomoki Todo, Gang Zhao, et al.
Cancer Science
|
September 5, 2019
Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis
Erna Raja, Masato Morikawa, Jun Nishida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 19, 2006
Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy
Ta-Chiang Liu, Tingguo Zhang, Hiroshi Fukuhara, et al.
Page
of 10